Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Pluristem Therapeutics, Inc (PSTI US)
Watchlist
8
Analysis
Health Care
•
Israel
Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
14 Oct 2022 00:30
Current report pursuant to Section 13 or 15(d) (PDF)
Attachment
Exchange Announcement •
29 Sep 2022 17:57
Current report pursuant to Section 13 or 15(d) (PDF)
Attachment
Exchange Announcement •
22 Sep 2022 01:16
US SEC Form 424B5 for Pluristem Therapeutics Inc
Attachment
Exchange Announcement •
22 Sep 2022 00:01
Annual report pursuant to Section 13 or 15(d) (PDF)
Attachment
Exchange Announcement •
25 Jul 2022 17:38
Current report pursuant to Section 13 or 15(d) (PDF)
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x